发布求助
文献互助 智能选刊 最新文献

EMJ Respiratory最新文献

筛选
英文 中文
Incidentally Detected PET-CT Imaging Findings Of COVID-19 Pneumonia: A Retrospective Study During Local Pandemic Era 偶然发现的COVID-19肺炎PET-CT影像学表现:局部大流行时期的回顾性研究
EMJ Respiratory Pub Date : 2022-06-20 DOI: 10.33590/emjrespir/22-00043
M.J. Akshit Aiyappa, J. Abraham
{"title":"Incidentally Detected PET-CT Imaging Findings Of COVID-19 Pneumonia: A Retrospective Study During Local Pandemic Era","authors":"M.J. Akshit Aiyappa, J. Abraham","doi":"10.33590/emjrespir/22-00043","DOIUrl":"https://doi.org/10.33590/emjrespir/22-00043","url":null,"abstract":"Background: COVID-19 has been declared a global health emergency by the World Health Organisation (WHO). Commonly, a CT chest scan is performed to detect any early findings of COVID-19 pneumonia before the onset of clinical symptoms. In this article, the authors reported COVID-19 pneumonia in patients undergoing positron emission tomography with 2-deoxy-2-(fluorine-18) fluoro-D-glucose integrated with CT (18F-FDG PET/CT) examinations for early isolation and necessary management.\u0000\u0000Methods: One hundred and twelve patients who underwent 18F-FDG PET/CT imaging for routine oncological examination were considered for the study, and these subject scans were taken during a period of December 2020–August 2021. Following which, reverse transcription-PCR testing was requested for confirmation.\u0000\u0000Results: Amongst the 112 patients, 45 (40%) patients showed features of COVID-19 pneumonia on PET/CT imaging. Reverse transcription-PCR testing carried out for these patients confirmed the infection in 38 individuals (84%).\u0000\u0000Conclusion: 18F-FDG PET/CT is sensitive for early detection of COVID-19 pneumonia, so as to minimise further spread of infection and apply adequate measures for prevention.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123192145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epstein–Barr Virus-Induced Acute Hepatitis, Pancreatitis, and Pneumonitis in a Young Immunocompetent Adult: A Case Report Epstein-Barr病毒诱导的急性肝炎、胰腺炎和肺炎在一个年轻的免疫能力的成年人:一个病例报告
EMJ Respiratory Pub Date : 2021-12-13 DOI: 10.33590/emjrespir/21-00050
E. Fiani, Rafca Challita, Hanaa Badawaki, Khaled Soukarieh, Melissa Kyriakos Saad, E. Saikaly
{"title":"Epstein–Barr Virus-Induced Acute Hepatitis, Pancreatitis, and Pneumonitis in a Young \u0000Immunocompetent Adult: A Case Report","authors":"E. Fiani, Rafca Challita, Hanaa Badawaki, Khaled Soukarieh, Melissa Kyriakos Saad, E. Saikaly","doi":"10.33590/emjrespir/21-00050","DOIUrl":"https://doi.org/10.33590/emjrespir/21-00050","url":null,"abstract":"Epstein–Barr virus (EBV) is a common herpes virus (human herpesvirus type 4) that usually manifests as infectious mononucleosis or persists asymptomatically for life. EBV can also be associated with different types of malignancy such as T cell lymphoma, B cell lymphoma, Hodgkin lymphoma, and oropharyngeal squamous cell and nasopharyngeal carcinoma. Pneumonia is a very rare complication of EBV infection, but it has been reported to occur even in the absence of mononucleosis.\u0000\u0000This article highlights the case of 35-year-old female who developed acute pancreatitis and acute respiratory failure related to EBV infection. The patient progressively recovered on antiviral therapy and steroids.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122733276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Stroke in a Patient with Recurrent Meningeal Tuberculosis and HIV Coinfection 复发性脑膜结核合并HIV感染患者的脑卒中
EMJ Respiratory Pub Date : 2021-10-19 DOI: 10.33590/emjrespir/21-00075
Dilia Fontalvo-Rivera, G. Mora-García, Gustavo Jiménez-Borré, Javier Segovia-Fuentes, Doris Gómez-Camargo
{"title":"Stroke in a Patient with Recurrent Meningeal Tuberculosis and HIV Coinfection","authors":"Dilia Fontalvo-Rivera, G. Mora-García, Gustavo Jiménez-Borré, Javier Segovia-Fuentes, Doris Gómez-Camargo","doi":"10.33590/emjrespir/21-00075","DOIUrl":"https://doi.org/10.33590/emjrespir/21-00075","url":null,"abstract":"Recurrent tuberculous meningitis can have a non-specific clinical presentation when it presents as a co-infection with HIV and can resemble other causes of subacute and chronic meningitis, leading to unwanted outcomes; for this reason, timely diagnoses are required. The most widely used microbiological diagnostic methods can be of low sensitivity or have delayed results.\u0000\u0000The aim of this article is to present a clinical case of recurrent tuberculous meningitis with a clinical presentation of stroke due to a basal cistern ischaemic lesion in a patient co-infected with HIV, who had a microbiological confirmation and a drug sensitivity study with phenotypic and molecular tests.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130003374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Embolism in Vaccine-Induced Thrombotic Thrombocytopaenia: Under-Reported? 疫苗诱导的血栓性血小板减少症肺栓塞:报道不足?
EMJ Respiratory Pub Date : 2021-10-19 DOI: 10.33590/emjrespir/21-00160
Veerle Leenaerts, M. Staes, J. Callens, P. Monballyu
{"title":"Pulmonary Embolism in Vaccine-Induced Thrombotic Thrombocytopaenia: Under-Reported?","authors":"Veerle Leenaerts, M. Staes, J. Callens, P. Monballyu","doi":"10.33590/emjrespir/21-00160","DOIUrl":"https://doi.org/10.33590/emjrespir/21-00160","url":null,"abstract":"Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare, newly described syndrome characterised by thrombocytopenia and thrombosis 5–24 days after administration of an adenoviral vector-based COVID-19 vaccine. It resembles heparin-induced thrombocytopenia and, therefore, diagnostics and treatment are similar. Early recognition is essential to avoid potentially fatal outcomes. This article describes a case of VITT with symptomatic cerebral venous-sinus thrombosis and splanchnic vein thrombosis, as well as asymptomatic pulmonary embolism in a 49-year-old male. The authors discuss VITT, focusing on the possibility of pulmonary embolism being under-reported, diagnostic criteria, differential diagnosis, and treatment.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127245859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Latest ERS Guidelines on non-CPAP Therapies in Obstructive Sleep Apnoea 阻塞性睡眠呼吸暂停非cpap治疗的最新ERS指南
EMJ Respiratory Pub Date : 2021-10-19 DOI: 10.33590/emjrespir/21f1019
H. Patel
{"title":"Latest ERS Guidelines on non-CPAP Therapies in Obstructive Sleep Apnoea","authors":"H. Patel","doi":"10.33590/emjrespir/21f1019","DOIUrl":"https://doi.org/10.33590/emjrespir/21f1019","url":null,"abstract":"During the European Respiratory Society (ERS) International Congress 2021, speakers discussed the latest updates to the ERS guidelines on non-CPAP therapies in obstructive sleep apnoea. The new recommendations were drawn following a systemic review of the literature.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"20 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131673273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Biomarkers for Lung Disease 肺部疾病生物标志物研究进展
EMJ Respiratory Pub Date : 2021-10-19 DOI: 10.33590/emjrespir/21f11019
Evan Kimber
{"title":"Advances in Biomarkers for Lung Disease","authors":"Evan Kimber","doi":"10.33590/emjrespir/21f11019","DOIUrl":"https://doi.org/10.33590/emjrespir/21f11019","url":null,"abstract":"Bringing together a collection of the most forward-thinking approaches to lung disease, the European Respiratory Society (ERS) International Congress 2021 hosted a virtual session on imaging biomarkers. Four insightful presentations discussed the shift towards more longitudinal imaging approaches for lung disease and provided an overview of quantitative analyses with computer-trained algorithms. Alongside this was a discussion of the use of novel biomarkers such as pleuroparenchymal fibroelastosis.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"85 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124579335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-COVID-19 Pulmonary Fibrosis: Report of Two Cases 新冠肺炎后肺纤维化2例报告
EMJ Respiratory Pub Date : 2021-09-13 DOI: 10.33590/emjrespir/20-00270
S. Karmakar, Priya Sharma, A. Harishkumar, D. Rai
{"title":"Post-COVID-19 Pulmonary Fibrosis: Report of Two Cases","authors":"S. Karmakar, Priya Sharma, A. Harishkumar, D. Rai","doi":"10.33590/emjrespir/20-00270","DOIUrl":"https://doi.org/10.33590/emjrespir/20-00270","url":null,"abstract":"COVID-19 caused by severe acute respiratory syndrome coronavirus 2 has led to a pandemic situation worldwide. However, remarkable progress has been made in evolving policies, strengthening healthcare efforts, and pharmacotherapy. As more patients are recovering from COVID-19, clearer concepts about possible short- and long-term complications are emerging. Respiratory failure is the most common morbidity in hospitalised patients, and post-COVID-19 pulmonary fibrosis is the most common respiratory complication after recovery. The authors report two cases of COVID-19 pneumonia with respiratory failure who were cured but developed pulmonary fibrosis with restrictive lung disease in the follow-up period.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122681689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
SARS-CoV-2 and Cystic Fibrosis: Expectations Versus Reality, a Literature Review SARS-CoV-2与囊性纤维化:期望与现实，文献综述
EMJ Respiratory Pub Date : 2021-08-29 DOI: 10.33590/emjrespir/20-00275
M. Bantounou, Josip Plascevic
{"title":"SARS-CoV-2 and Cystic Fibrosis: Expectations Versus Reality, a Literature Review","authors":"M. Bantounou, Josip Plascevic","doi":"10.33590/emjrespir/20-00275","DOIUrl":"https://doi.org/10.33590/emjrespir/20-00275","url":null,"abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, is expected to cause severe illness in people with cystic fibrosis (CF). The infection prevalence and clinical outcomes of this patient cohort to SARS-CoV-2 were explored, alongside contributing factors to the observed response. \u0000Search terms were entered into Medline/PubMed and Embase databases, with relevant published papers written in English chosen. \u0000The COVID-19 trajectory in people with CF (including children) was similar to the general population. Specifically, in Veneto, Italy, the infection rate of people with CF was nearly half compared to the general population (0.19% versus 0.40%, respectively). Similarly, in Spain, the cumulative incidence of COVID-19 was lower compared to the general population: 32/10,000 and 49/10,000 respectively. Likewise, in Belgium 2.7% of patients with CF had SARS-CoV-2 antibodies compared with 4.3% of the general population. Moreover, in Europe, fewer CF–COVID-19 cases and deaths were reported compared to the general population (1.1%, 0.9%; and 3.2%, 2.3%, respectively). Overall, worse outcomes in CF were associated with poorer lung function and post-transplant status. \u0000The encouraging response of people with CF to COVID-19 is hypothesised as due to higher levels of anti-inflammatory angiotensin-1-7 and lower levels of pro-inflammatory IL-6 and protease transmembrane serine protease-2, utilised by SARS-CoV-2 to penetrate cells. Additionally, the use of CF medication, chiefly Dornase alfa and CF transmembrane conductance regulator modulators as well as CF cohort characteristics, predominantly younger age, and early isolation might have mitigated COVID-19 severity. \u0000Thus, people with CF do not appear to have a higher COVID-19 infection prevalence or worse clinical outcomes compared to the general population.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114226160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information and Communication Technology in the Fight Against the COVID-19 Pandemic/Infodemic 信息和通信技术在抗击COVID-19大流行/信息大流行中的作用
EMJ Respiratory Pub Date : 2021-02-09 DOI: 10.33590/emjinnov/20-00220
S. Kobayashi
{"title":"Information and Communication Technology in the Fight Against the COVID-19 Pandemic/Infodemic","authors":"S. Kobayashi","doi":"10.33590/emjinnov/20-00220","DOIUrl":"https://doi.org/10.33590/emjinnov/20-00220","url":null,"abstract":"","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"10 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114113116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Physiological Comorbidity Care: The Unmet Need in Patients with Chronic Lung Diseases 生理合并症护理:慢性肺病患者未满足的需求
EMJ Respiratory Pub Date : 2020-11-02 DOI: 10.33590/emjrespir/201102
{"title":"Physiological Comorbidity Care: The Unmet Need in Patients with Chronic Lung Diseases","authors":"","doi":"10.33590/emjrespir/201102","DOIUrl":"https://doi.org/10.33590/emjrespir/201102","url":null,"abstract":"PSYCHOLOGICAL distress significantly impacts patient quality of life (QoL), treatment adherence, mortality, and morbidity. However, patient distress is often under supported throughout a patient’s treatment journey. The virtual European Respiratory Society (ERS) International Congress 2020 session ‘Fear and Anxiety, Psychological Wellbeing and Prevention of Psychological Distress in Chronic Lung diseases,’ underscored the importance of addressing these needs in chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) patients, focussing on disease-specific fears, cognitive therapies, palliative care, and the importance of empathy.","PeriodicalId":300382,"journal":{"name":"EMJ Respiratory","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123793391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信